LAMEA Remote Patient Monitoring Devices Market By Product Type (Cardiac Monitors - ECG Monitoring, Heart Rate Monitors, Fetal Heart Rate Monitor, Blood Pressure Monitors; Respiratory Monitors - Respiration Rate Monitor Systems, Spirometers, Sleep Apnea Monitor; Hematological Monitors - Blood Glucose Monitor, Prothrombin Time Monitor), Indications, End User
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Remote Patient Monitoring Devices Market
Market Report Description
Remote Patient Monitoring (RPM) Device also known as homecare Telehealth, is a technological device that are used for continually monitoring heart activity, blood pressure, pulse rate, body temperature and other patient related activities. These devices are also useful in inspecting the chronic diseases. The health professionals can examine their patients from the remote locations is one of the major breakthroughs in terms of healthcare advancements. To perform a routine test patient can use the mobile medical devices and can easily send the test data to their respective healthcare surgeon with the help of smartphones or computers. In the 24th Annual Health Sciences Tax Conference held in December 2014, experts have stated about the leverage of smartphones by the end users such as life science companies, tech start-ups and providers in order to offer remote monitoring to patients worldwide. Additionally, they stated the transition to value-based reimbursement causing the disruption to the health care business model. Reduction in the cost of the hospitals stays, overcrowding in the diagnostic centres, and growing patient care services are some of the key drivers for the growth of the Remote patient devices market. However, lack of skilled professionals, ineffective reimbursement guidelines and issues in device functions would hamper the growth of the market.
Based on the product, the Remote Patient Monitoring Devices market is segmented into Cardiac Monitors, Respiratory Monitors and Hematological Monitors. The Cardiac Monitors market is segmented into ECG Monitoring, Heart Rate Monitors, Fetal Heart Rate Monitor and Blood Pressure Monitors. Respiratory Monitors are further segmented into Respiration Rate Monitor, Spirometers and Sleep Apnea Monitor. The Hematological Monitors market is further segmented into Blood Glucose Monitor and Prothrombin Time Monitor. Based on the Indications, the market is segmented into Cardiac Arrhythmia, Diabetes, Ischemic diseases, Hypertension, Sleep apnea, Chronic respiratory diseases and Hyperlipidemia. Based on End User Type, the market is segmented into Hospitals, Homecare Settings and Others. Based on Country, LAMEA Remote Patient Monitoring Devices market is segmented into Brazil, ARGENTINA, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA. Brazil remained the dominant Country in the LAMEA Remote Patient Monitoring Devices market in 2015. UAE and Saudi Arabia would witness promising CAGR during the forecast period (2016-2022).
The report covers the analysis of key stake holders of the Remote Patient Monitoring Devices market. Key companies profiled in the report include Abbott Laboratories, Medtronic Plc, Roche Diagnostics, Siemens Healthcare (Siemens AG), Omron Corporation, Nihon Kohden Corporation, Honeywell International, Inc., Lifewatch and Philips Group.
North America Remote Patient Monitoring Devices Market
Europe Remote Patient Monitoring Devices Market
Asia Pacific Remote Patient Monitoring Devices Market